GORIVITUG
UNII 83DC7W9PBC

Substance Identification & Data

This profile provides standardized clinical and technical data for Gorivitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 83DC7W9PBC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2765086-18-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

83DC7W9PBC

CAS Registry Number

2765086-18-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GORIVITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190327

National Cancer Institute reference terminology for clinical and research data.

INN ID

12616

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-259

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gorivitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GORIVITUG

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-453) (VH (HOMO SAPIENS IGHV3-64D*06 (94.9%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT (8.8.16) (26-33.51-58.97-112)) (1-123)-HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 K120 (220) (124-221), HINGE 1-15 (222-236), CH2 (237-346), CH3 D12 (362), L14 (364) (347-451), CHS (452-453)) (124-453)), (226-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01(96.8%) -IGKJ3*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

GORIVITUG [INN]

GORIVITUG [USAN]

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL REGN15160 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN15160 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY

Technical Codes

REGN15160

REGN-15160

External Clinical & Regulatory Resources

Previous UNII83DC4O5TD3

Next UNII83DNB5FIRF